I
Integrity Technology Group Inc
SSE:688244
Integrity Technology Group Inc
SSE:688244
Price:
19.37
CNY
-1.22%
Market Cap:
¥2.9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
I
|
Integrity Technology Group Inc
SSE:688244
|
CN |
|
Shanghai Titan Scientific Co Ltd
SSE:688133
|
CN |
|
Helix BioMedix Inc
OTC:HXBM
|
US |
Balance Sheet
Balance Sheet Decomposition
Integrity Technology Group Inc
Integrity Technology Group Inc
Balance Sheet Decomposition is not available for
Integrity Technology Group Inc
Integrity Technology Group Inc
Balance Sheet
Integrity Technology Group Inc
Integrity Technology Group Inc
Currency: CNY
| Dec-2014 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
5
|
105
|
402
|
361
|
669
|
606
|
488
|
|
| Cash |
0
|
105
|
402
|
361
|
669
|
606
|
488
|
|
| Cash Equivalents |
5
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
160
|
100
|
70
|
|
| Total Receivables |
11
|
107
|
91
|
129
|
220
|
318
|
376
|
|
| Accounts Receivables |
3
|
98
|
86
|
122
|
215
|
313
|
359
|
|
| Other Receivables |
8
|
10
|
5
|
6
|
5
|
6
|
16
|
|
| Inventory |
2
|
24
|
27
|
17
|
9
|
16
|
37
|
|
| Other Current Assets |
27
|
6
|
6
|
7
|
1
|
12
|
3
|
|
| Total Current Assets |
46
|
242
|
527
|
514
|
1 058
|
1 053
|
973
|
|
| PP&E Net |
1
|
88
|
83
|
78
|
70
|
69
|
71
|
|
| PP&E Gross |
0
|
88
|
83
|
78
|
70
|
69
|
71
|
|
| Accumulated Depreciation |
0
|
10
|
16
|
26
|
35
|
21
|
24
|
|
| Intangible Assets |
0
|
1
|
6
|
6
|
33
|
53
|
64
|
|
| Note Receivable |
0
|
0
|
4
|
4
|
7
|
7
|
6
|
|
| Long-Term Investments |
0
|
0
|
3
|
3
|
2
|
53
|
89
|
|
| Other Long-Term Assets |
1
|
5
|
5
|
7
|
9
|
13
|
15
|
|
| Total Assets |
47
N/A
|
336
+610%
|
628
+87%
|
612
-3%
|
1 180
+93%
|
1 248
+6%
|
1 220
-2%
|
|
| Liabilities | ||||||||
| Accounts Payable |
4
|
27
|
35
|
43
|
67
|
120
|
138
|
|
| Accrued Liabilities |
0
|
11
|
14
|
13
|
11
|
15
|
12
|
|
| Short-Term Debt |
0
|
10
|
39
|
11
|
15
|
18
|
18
|
|
| Current Portion of Long-Term Debt |
0
|
7
|
7
|
1
|
1
|
2
|
3
|
|
| Other Current Liabilities |
5
|
46
|
70
|
33
|
21
|
15
|
10
|
|
| Total Current Liabilities |
9
|
101
|
166
|
101
|
116
|
169
|
181
|
|
| Long-Term Debt |
0
|
17
|
9
|
2
|
2
|
2
|
4
|
|
| Minority Interest |
0
|
0
|
0
|
1
|
2
|
1
|
2
|
|
| Other Liabilities |
0
|
9
|
6
|
16
|
10
|
9
|
9
|
|
| Total Liabilities |
8
N/A
|
127
+1 411%
|
181
+42%
|
118
-35%
|
129
+10%
|
181
+40%
|
193
+6%
|
|
| Equity | ||||||||
| Common Stock |
12
|
32
|
35
|
35
|
47
|
69
|
102
|
|
| Retained Earnings |
3
|
5
|
47
|
94
|
145
|
161
|
153
|
|
| Additional Paid In Capital |
24
|
172
|
365
|
365
|
859
|
837
|
804
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
33
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
39
N/A
|
209
+437%
|
447
+114%
|
494
+11%
|
1 051
+113%
|
1 067
+1%
|
1 027
-4%
|
|
| Total Liabilities & Equity |
47
N/A
|
336
+610%
|
628
+87%
|
612
-3%
|
1 180
+93%
|
1 248
+6%
|
1 220
-2%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
38
|
152
|
152
|
152
|
152
|
152
|
150
|
|
Switch to:
Switch to:
See Also
Discover More
